glutathione peroxidase helps the body convert Extracellular GPx3 and Its Role in Cancer The Selenoprotein Glutathione Peroxidase 4:

A typical case is the development of glycogen synthase kinase-3 (GSK-3)/inhibitor of nuclear factor-B kinase- (IKK-) dual-target inhibitors, where the research team combined molecular docking with 200 ns MD simulation, not only verifying the binding stability of lead compounds but also discovering their unique hydrogen bond networks formed with the adenosine 5-triphosphate (ATP) binding pockets of both targets, ultimately achieving half maximal inhibitory concentration (IC 50 ) values of 12 nm and 8 nm for GSK-3 and IKK-, respectively (Roy Acharyya et al., 2022)

[DOI] [PMC free article] [PubMed] [Google Scholar] 158.Pietramaggiori G, Scherer SS, Cervi D, Klement G, Orgill DP

Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury

Hamiel CR, Pinto S, Hau A, Wischmeyer PE

"The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores"